https://www.marketscreener.com/quote/stock/DERMIRA-INC-18138387/news/Eli-Lilly-and-Company-and-Dermira-Present-New-Lebrikizumab-Phase-2B-Clinical-Data-Showing-Patients-w-33835798/?utm_source=telegram&utm_medium=social&utm_campaign=share